Information  X 
Enter a valid email address

Xaar PLC (XAR)

  Print      Mail a friend       Annual reports

Thursday 28 August, 2014

Xaar PLC

2014 Interim Results

RNS Number : 1747Q
Xaar PLC
28 August 2014
 



28 August 2014

 

Xaar plc

 

 

2014 INTERIM REPORT

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the inkjet printing technology Group headquartered in Cambridge, UK, has issued its interim report for the six months ended 30 June 2014.

 

Summary of results for the six months to 30 June 2014

 

Adjusted1

 

IFRS

 

H1 2014

H1 2013

 

H1 2014

H1 2013

Revenue

£60.4m

£67.2m

 

£60.4m

£70.2m

Gross profit

£28.5m

£36.5m

 

£28.5m

£39.5m

Gross margin %

47%

54%

 

47%

56%

Gross R&D investment

£9.2m

£7.1m

 

£9.2m

£7.1m

Net R&D investment

£5.9m

£7.1m

 

£5.9m

£7.1m

Operating margin %

26%

33%

 

25%

33%

Profit before tax

£16.1m

£22.3m

 

£15.3m

£23.4m

Diluted earnings per share

17.2p

23.5p

 

16.2p

24.6p

Net cash2 at period end

£48.1m

£49.4m

 

£48.1m

£49.4m

Dividend per share

3.0p

2.5p

 

3.0p

2.5p

                                                                                                                             

1 Excluding the impact of share-based payment charges, exchange differences relating to the Swedish operations, gains/losses on derivative financial instruments, research and development expenditure credits and £3.0 million of revenue recognised in H1 2013 which related to the settlement of under-reported licensee royalties for the period 2006 to 2012

2 Net cash includes cash, cash equivalents and treasury deposits

 

Key financial highlights

·      Revenue in line with expectations at £60.4 million in H1 2014, largely reflecting a return to more typical trading patterns around Chinese New Year following the exceptional experience of 2013

·      Strong gross margin and operating margin percentages (47% and 26% respectively) but reduced versus H1 2013, as a result of increased manufacturing capacity and reduced pricing

·      Gross R&D investment (before capitalisation of development costs relating to the Thin Film programme) increased by 30% to £9.2 million in H1 2014

·      Strong balance sheet maintained with net cash of £48.1 million

·      Interim dividend up 20% reflecting the introduction of a sustainable and progressive dividend policy

 

Operational highlights

·      New products announced to maintain clear leadership in ceramic tile decoration, extend inkjet into other tile manufacturing processes and increase sales in other applications

·      Growth in applications outside of ceramics disappointing, but future progress is expected as our partners continue to develop solutions with our technology

·      Pre-production activities continue within the 'Direct-to-Shape' application

·      Manufacturing capacity expansion programme will complete during September bringing total investment in the Huntingdon plant to c.£60 million

·      Thin Film programme remains on track; decision reached on the manufacturing plan

 

Ian Dinwoodie, Chief Executive, commented:

 

"Following the exceptional experience of 2013, our business reverted to more typical trading patterns in the first half of 2014, characterised by limited visibility of short term demand and the usual seasonal lull around Chinese New Year.  Sales volumes into ceramic tile decoration, our largest application, stabilised in the first half of the year as expected, following the explosive growth of the last few years.  Our market leading position in ceramic tiles has, as previously announced, attracted competition, which has negatively impacted pricing, but we have strengthened our offering with several new product launches. 

 

In other applications, whilst the expected growth in sales has not yet materialised, progress is expected as our partners continue to develop their solutions. As highlighted in June, pre-production activities within the 'Direct-to-Shape' application continue, and our expectations of this opportunity for the longer term have strengthened.  Our Thin Film Programme, we believe, will open up multiple further markets to Xaar, significantly broadening the scale of the opportunity over the long term.

 

During the third quarter, demand from the ceramic tile decoration sector has softened, which we believe relates to a slowdown in construction activity in China.  In light of this, the Board's expectation for 2014 revenue has reduced to £115-125 million, with adjusted operating margin projected to be broadly in line with the 26% achieved in the first half of the year.  We remain excited about Xaar's long term potential at the centre of the digital inkjet revolution."

 

Contacts

Xaar plc


Ian Dinwoodie, Chief Executive

Today: 020-7353-4200

Alex Bevis, Finance Director

Thereafter: 01223-423663


www.xaar.com

Tulchan Communications


Tom Buchanan

020-7353-4200

Christian Cowley


 

 

CHAIRMAN'S STATEMENT

 

Introduction

Following the exceptional experience of 2013, our business reverted to more typical trading patterns in the first half of 2014, characterised by limited visibility of short term demand and the usual seasonal lull around Chinese New Year.  Sales volumes into ceramic tile decoration, our largest application, stabilised in the first half of the year as expected, following the explosive growth of the last few years.  In other applications, whilst the expected growth in sales has not yet materialised, future progress is expected as our partners continue to develop their solutions. 

 

The geographic split of our revenue based on the location of our customers (and not necessarily end users) shifted in line with the Chinese seasonality referred to above; sales to Asia reduced to 41% of the total for H1 2014 (H1 2013: 45%), EMEA increased to 54% (H1 2013: 50%) and the Americas remained unchanged at 5% of Group sales.

 

In terms of market segmentation, Industrial remains dominant at 73% (H1 2013: 71%), Graphic Arts 10% (H1 2013: 11%), Packaging 11% (H1 2013: 12%) and the legacy licensee royalty income at 6% (H1 2013: 6%).

 

The Group continues to maintain a strong balance sheet with net cash at 30 June 2014 of £48.1 million (31 December 2013: £53.5 million).  As expected, cash balances reduced during the first half of the year due to investment in manufacturing and development assets, increased working capital and dividend payments.

 

Results

Revenue for the six months ended 30 June 2014 was £60.4 million (H1 2013: adjusted £67.2 million; H2 2013: £66.9 million).  Product sales were £57.1 million (H1 2013: £63.9 million; H2 2013: £63.3 million). Royalty revenue was £3.3 million (H1 2013: adjusted £3.3 million; H2 2013: £3.6 million).

 

As previously stated, the profit margins achieved in 2013 were flattered by levels of asset utilisation that were unsustainable over the longer term.  Profit margins in 2014 have therefore reduced as a result of an increase in manufacturing capacity.  Gross margin declined to 47% (H1 2013: adjusted 54%; H2 2013: 52%) reflecting both the increased manufacturing capacity and also lower pricing.  Similarly, adjusted operating margin reduced to 26% (H1 2013: 33%; H2 2013: 28%).

 

Adjusted profit before tax for the period was £16.1 million (H1 2013: £22.3 million; H2 2013: £18.8 million).

 

Adjusted profit before tax is stated after capitalisation of £3.3 million of internal development costs on the Group's Thin Film programme (Platform 4).  Following the internal technology demonstration in December 2013, the programme met all of the criteria under IAS 38, requiring development costs to be capitalised from January 2014.  The programme differs from normal Xaar product developments because the programme will establish a technology platform for a portfolio of new products, which is expected to be a very substantial investment and will take several years to complete.  There has been no change in accounting policy; capitalisation of development costs on specific product developments will continue to be assessed prudently against the IAS 38 criteria.

 

Outlook

We remain entirely focused on our market of industrial and commercial inkjet. This will always be technologically and operationally challenging, and that of course provides a significant barrier to entry. Our considerable experience can only help Xaar remain a leader in this market that offers enormous potential. To capitalise on that we must continue to develop technology and products that can successfully convert printing applications from analogue to digital processes.

 

We continue to lead the market in ceramic tile decoration and remain excited by the future potential offered by tile decoration and a number of other ceramic tile processes. In addition, our partners continue to develop solutions with our technology across multiple applications in both the packaging and industrial markets.  As highlighted in June, pre-production activities within the 'Direct-to-Shape' application continue, and our expectations of this opportunity for the longer term have strengthened.  Despite being long lived, Grand and Wide Format Graphics remains an opportunity and we are targeting to regain share. Our Thin Film Programme, we believe, will open up multiple further markets to Xaar, significantly broadening the total opportunity over the long term.

 

During the third quarter, demand from the ceramic tile decoration sector has softened, which we believe relates to a slowdown in construction activity in China.  In light of this, the Board's expectation for 2014 revenue has reduced to £115-125 million, with adjusted operating margin projected to be broadly in line with the 26% achieved in the first half of the year.

 

Business Commentary

Our rapid progress over the last few years can largely be attributed to our success in transforming the decoration process of ceramic tiles. It is estimated that approximately half of the world's 10 billion square metres of annual ceramic tile output is now decorated using digital inkjet, with Xaar's technology leading the way.  Our dominant position has, as expected, attracted competition which has impacted pricing, but we have announced new products to maintain our market leadership.  The ceramic tile market remains a significant opportunity for Xaar, in terms of imaging onto tiles and also other decorative and structural processes.

 

In May 2014, three new printheads were announced: the Xaar 1002 GS40; the Xaar 1002 SBX; and the Xaar 001, targeting ceramic tile applications beyond the current digital decoration process. Xaar's extended printhead range provides the technology to deliver even bigger advantages by achieving: higher levels of colour intensity; digital secondary glaze and special effects; and, volume digital deposition for base glaze and structure.  We believe that enhanced colour intensity will be very attractive to the tile industry and their customers, and this has been borne out by the reaction from our OEM (original equipment manufacturers) partners. The structure, glazing and finishing processes are all aspects of tile decoration that have yet to be 'digitalised', and provide further examples of Xaar bringing its disruptive technology to new areas, giving significant advantages to our OEMs and end customers.

 

In July 2014, the Group announced the Xaar 501; a product built on the success of the 1002, aimed at providing higher levels of performance in graphics and packaging. Field trials are currently in progress, which have resulted in a final round of product bug fixes. We anticipate this product will enable us to recapture some market share in the Grand and Wide Format Graphics sector.

 

The labels market has not yet shown the progress we might have expected, but the potential remains strong. We remain excited about the possibilities with 'Direct-to-Shape', a process that eliminates labels and allows printing on non-flat surfaces such as bottles. This is technologically challenging and our partners have been investigating this opportunity over the past number of years.  The first field trials are being undertaken during 2014 and Xaar is at the heart of these developments.

 

Progress continues with our Thin Film development to deliver Platform 4 (P4) aimed at opening up further market opportunities including commercial print and textiles. As previously reported, we have substantially increased R&D headcount and this has resulted in an increasingly talented international workforce, where efforts are clearly segregated between Bulk technology and Thin Film technology.

 

The Company has now finalised its strategy for the production of the first Thin Film piezo (P4) products, with sales expected to commence in late 2016. A hybrid manufacturing model combining both outsourced and in-house processing has been selected.  The initial capital investment of approximately £10 million required to support the model, will be funded from existing cash resources.

 

Our latest manufacturing capacity expansion programme for Bulk Piezo products is nearing completion ensuring we have the resources to continue with our anticipated future growth. Meanwhile we continue to host and impress our customers and partners at our excellent main manufacturing facility at Huntingdon.

 

Dividend

Based on the Group's long term growth potential and the decision reached on the manufacturing plan for the Thin Film piezo programme, the Board has decided to adopt a sustainable and progressive dividend policy which takes into account the Group's future prospects, its underlying profitability and the future cash requirements of the business. 

 

The Board has declared a 2014 interim dividend of 3 pence, a 20% increase over the 2013 interim dividend, which will be paid on 3 October 2014 to shareholders on the register at close of business on 5 September 2014.

 

For 2014 and future periods, the Board expects the ratio of interim dividend to the final dividend to be around 1:2, implying a total dividend of 9 pence for 2014, which would be a 12.5% increase over the 8 pence paid for 2013.

 

Board

We were pleased to welcome Edmund Creutzmann to the Board during April 2014 as Chief Technical Officer. He has over 30 years of digital printing R&D experience spanning LED, electrophotographic and inkjet imaging technologies. He received his degree in physics and engineering from the University of Applied Sciences, Munich. Most recently he was Vice President, Printer Technology at Océ Printing Systems GmbH (Canon Group) in Germany.

 

As a consequence, Ramon Borrell, Director of R&D, has stepped down from the Board to fully focus his efforts on Thin Film development (P4). I take this opportunity to thank Ramon for all his contributions to the Board over the past seven years and wish him all success in bringing our next generation of technology (P4) to market dominance.

 

As previously announced, our Chief Executive of over 11 years, Ian Dinwoodie, announced his intention to retire next year. Consequently a global search has commenced to locate the right calibre individual and we are confident of a timely replacement. We have also decided to increase the number of Board members and are in the process of recruiting a further Non-Executive Director to complement the existing three (including myself as Chairman).

 

 

DIRECTORS' RESPONSIBILITIES STATEMENT

We confirm that to the best of our knowledge:

(a)   the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the EU and gives a true and fair view of the assets, liabilities, financial position and profit of the Group.

(b)   the interim management report includes a fair review of the information required by DTR 4.2.7R:

(i)            an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements, and

(ii)           a description of principal risks and uncertainties for the remaining six months of the year.

(c)   the interim management report includes a fair review of the information required by DTR 4.2.8R:

(i)            related parties transactions that have taken place in the first six months of the current financial year that have materially affected the financial position or performance of the Group in that period, and

(ii)           any changes in the related parties transactions described in the Annual Report 2013 that could have a material effect on the financial position or performance of the Group in the current period.

 

By order of the board

 

 

IAN DINWOODIE

CHIEF EXECUTIVE

 

 

ALEX BEVIS

FINANCE DIRECTOR AND COMPANY SECRETARY

 

28 August 2014

 

 

 

 

 

CONDENSED CONSOLIDATED INCOME STATEMENT

 

 

 

FOR THE SIX MONTHS ENDED 30 JUNE 2014

 

 

 

 

 

 

Six months

ended

Six months
 ended

Twelve months ended

 

 

30 June

30 June

31 December

 

 

2014

2013

2013

 

 

(reviewed)

(reviewed)

(audited)

 

Notes 

£'000

£'000

£'000

 

 

 

 

 

Revenue

3

60,444

70,230

137,128

Cost of sales

 

(31,920)

(30,735)

(63,114)

Gross profit

 

28,524

                  39,495

           74,014

Research and development expenses

 

           (5,865)

           (7,075)

      (16,389)

Research and development expenditure credit

 

241

-

586

Sales and marketing expenses

 

               (2,809)

               (3,069)

            (6,114)

General and administrative expenses

 

     (5,046)

     (6,141)

(12,398)

Operating profit

 

15,045

23,210

              39,699

Investment income

 

247

192

                    443

Finance costs

 

              -

              (40)

                 (55)

Profit before tax

 

15,292

23,362

              40,087

Tax

4

(2,797)

(4,642)

          (8,226)

Profit for the period attributable to shareholders

 

12,495

   18,720

               31,861

Earnings per share

 

 

 

 

Basic

5

16.7p

25.5p

43.3p

Diluted

5

16.2p

24.6p

41.6p

 

 

 

 

 

Dividends paid in the period amounted to £4,124,000 or 5.5p per share 2013 final dividend (six months to 30 June 2013: £2,211,000 or 3.0p per share 2012 final dividend; twelve months to 31 December 2013: £4,059,000 or 5.5p per share being 3.0p per share 2012 final dividend and 2.5p per share 2013 interim dividend).

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

FOR THE SIX MONTHS ENDED 30 JUNE 2014

 

 

 

 

Six months

ended

Six months
 ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Profit for the period attributable to shareholders

12,495

18,720

               31,861 

Exchange differences on translation of net investment

(46)

56

(7)

Tax benefit on share option gains

850

-

1,379

Other comprehensive income for the period

804

56

1,372

Total comprehensive income for the period

13,299

18,776

33,233

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

AS AT 30 JUNE 2014

 

 

 

As at

As at

 

30 June

31 December

 

2014

2013

 

(reviewed)

(audited)

 

 £'000

 £'000

Non-current assets

 

 

Goodwill

         720

         720

Other intangible assets

6,407

   3,387

Property, plant and equipment

   38,818

   38,452

Investments

1,000

1,000

Deferred tax asset

           1,287

           4,308

 

                     48,232

                     47,867

Current assets

 

 

Inventories

                     17,401

                     15,285

Trade and other receivables

                     16,732

                     15,441

Current tax asset

1,164

782

Treasury deposits

                     16,000

22,000

Cash and cash equivalents

                     32,141

31,485

Derivative financial instruments

-

6

 

                     83,438

84,999

Total assets

131,670

132,866

Current liabilities

 

 

Trade and other payables

(11,665)

           (19,225)

Other financial liabilities

                 (45)

                 (57)

Current tax liabilities

              (168)

              (1,848)

Provisions

   (549)

   (1,074)

 

          (12,427)

          (22,204)

Net current assets

                     71,011

62,795

Non-current liabilities

 

 

Deferred tax liabilities

           (368)

           (328)

Other financial liabilities

                   (341)

                   (292)

Total non-current liabilities

                 (709)

                 (620)

Total liabilities

         (13,136)

         (22,824)

Net assets

                   118,534

110,042

Equity

 

 

Share capital

  7,655

  7,589

Share premium

26,158

25,484

Own shares

             (3,796)

             (4,066)

Other reserves

9,668

8,610

Translation reserve

304

350

Retained earnings

78,545

72,075

Equity attributable to shareholders

118,534

110,042

Total equity

118,534

110,042

 

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY 

 

 

 

 

FOR THE SIX MONTHS ENDED 30 JUNE 2014

 

 

 

 

 

 

 

 

Share

Share

Own

Other

Translation

Retained

 

 

capital

premium

shares

reserves

reserve

earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balances at 1 January 2014

7,589

25,484

(4,066)

8,610

350

72,075

110,042

Profit for the period

-

-

-

-

-

12,495

12,495

Exchange differences on translation of net investment

-

-

-

-

(46)

-

(46)

Tax benefit on share option gains

-

-

-

-

-

850

850

Total comprehensive income for the period

           -

            -

          -

            -

(46)

13,345

13,299

Issue of share capital

66

674

-

-

-

(28)

712

Own shares sold in the period

-

-

270

-

-

(9)

261

Dividends (note 6)

-

-

-

-

-

(4,124)

(4,124)

Deferred tax charge on share options

-

-

-

-

-

(2,714)

(2,714)

Credit to equity for equity-settled share-based payments

-

-

-

1,058

-

-

1,058

Balance at 30 June 2014

7,655

  26,158

(3,796)

9,668

304

78,545

118,534

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Share

Share

Own

Other

Translation

Retained

 

 

capital

premium

shares

reserves

reserve

earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balances at 1 January 2013

7,474

24,406

(4,215)

6,507

357

39,590

74,119

Profit for the period

-

-

-

-

-

18,720

18,720

Exchange differences on translation of net investment

-

-

-

-

          56

-

56

Total comprehensive income for the period

-

-

-

-

     56

18,720

18,776

Issue of share capital

49

634

-

-

-

(3)

680

Own shares sold in the period

-

-

149

-

-

(24)

125

Dividends (note 6)

-

-

-

-

-

(2,211)

(2,211)

Deferred tax benefit on share options

-

-

-

-

-

2,516

2,516

Credit to equity for equity-settled share-based payments

-

-

-

967

-

-

967

Balance at 30 June 2013

7,523

  25,040

(4,066)

7,474

   413

58,588

94,972

 

 

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

 

 

FOR THE SIX MONTHS ENDED 30 JUNE 2014

 

Six months

ended

Six months
 ended

Twelve months ended

 

 

30 June

30 June

31 December

 

 

2014

2013

2013

 

 

(reviewed)

(reviewed)

(audited)

 

Note

£'000

£'000

£'000

Net cash from operating activities

8

                9,010

                27,259

45,093

Investing activities

 

 

 

 

Investment income

 

197

                64

278

Acquisition of investment bond

 

-

-

(1,000)

Purchases of property, plant and equipment

 

(7,793)

       (5,592)

(16,713)

Proceeds on disposal of property, plant and equipment

 

8

               2

42

Expenditure on capitalised product development and software 

(3,453)

            (17)

(245)

Net cash used in investing activities

 

(11,041)

       (5,543)

(17,638)

Financing activities

 

 

 

 

Dividends paid

(4,124)

         (2,211)

(4,059)

Movement in treasury deposits

 

                   6,000

                  (8,000)

(18,000)

Proceeds from the sale of ordinary share capital

 

261

125

125

Proceeds from issue of ordinary share capital

 

712

              680

1,147

Finance costs

 

-

              (40)

(55)

Repayments of borrowings

 

-

             (594)

(594)

Net cash from/(used in) financing activities

 

2,849

         (10,040)

(21,436)

Net increase in cash and cash equivalents

 

818

        11,676

6,019

Effect of foreign exchange rate changes

 

(162)

            271

20

Cash and cash equivalents at beginning of period

 

31,485

            25,446

25,446

Cash and cash equivalents at end of period

 

32,141

                  37,393

31,485

 

Cash and cash equivalents (which are presented as a single class of asset on the face of the condensed consolidated statement of financial position) comprise cash at bank and other short term highly liquid investments with a maturity of three months or less at the period end.

 

1. Basis of preparation and accounting policies

Basis of preparation

These interim financial statements have been prepared in accordance with the accounting policies set out in the Group's Annual Report and Accounts 2013 on pages 79 to 85 and were approved by the Board of Directors on 28 August 2014. The interim financial statements for the six months ended 30 June 2014 have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the European Union. The interim financial statements do not include all the information and disclosures in the annual financial statements and should be read in conjunction with the Group's annual financial statements as at 31 December 2013.

The financial information in these interim financial statements for the six months ended 30 June 2014, does not constitute statutory financial statements as defined in section 434 of the Companies Act 2006. The Group's Annual Report for the year ended 31 December 2013 has been delivered to the Registrar of Companies and the auditor's report on those financial statements was not qualified and did not contain statements made under section 498(2) or (3) of the Companies Act 2006.

The interim financial statements are unaudited but have been reviewed by the auditor Deloitte LLP. The report of the auditor to the Group is set out at the end of this announcement.

Significant accounting policies

The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 December 2013.

Risks and uncertainties

An outline of the key risks and uncertainties faced by the Group is detailed on pages 24 and 25 of the Xaar plc Annual Report and Accounts 2013 (available at www.xaar.com). It is anticipated that the risk profile will not significantly change for the remainder of the year. Risk is an inherent part of doing business and the strong cash position of the Group along with the underlying profitability of the core business leads the Directors to believe that the Group is well placed to manage business risks successfully.

Going concern

The Group's forecasts and projections, taking account of reasonably possible changes in trading performance, support the conclusion that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future, a period not less than 12 months from the date of this report. Accordingly, the going concern basis of preparation has been adopted in preparing the interim financial statements.

 

2. Reconciliation of adjusted financial measures

 

Six months ended

Six months ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Revenue

60,444

70,230

137,128

Non-recurring royalty income

-

(2,994)

(2,994)

Adjusted revenue

60,444

67,236

134,134

 

 

 

 

Profit before tax

15,292

23,362

40,087

Share-based payment charges

472

2,014

4,204

Exchange differences relating to the Swedish operations

523

(161)

416

Losses/(gains) on derivative financial instruments

6

107

(9)

Non-recurring royalty income

-

(2,994)

(2,994)

Research and development expenditure credit

(241)

 -

(586)

Adjusted profit before tax

16,052

22,328

41,118

 

Share-based payment charges include an IFRS 2 charge for the period of £1,058,000 (H1 2013: £968,000) and a credit relating to National Insurance on outstanding potential share option gains of £586,000 (H1 2013: charge of £1,046,000). The National Insurance credit in the period reflects a reduction in the potential liability due to the lower Xaar plc share price as at 30 June 2014 compared to as at 31 December 2013.

Exchange differences relating to the Swedish operations represent exchange gains or losses recorded in the consolidated income statement as a result of operating in Sweden.

Losses and gains on derivative financial instruments relate to the losses and gains made on forward currency contracts in 2014 and 2013.

Non-recurring royalty income related to the settlement of under-reported royalties payable by licensees for the period 2006 to 2012.

The research and development expenditure credit relates to the corporation tax relief receivable relating to qualifying research and development expenditure.

 

 

Six months ended

Six months ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

pence per share

pence per share

pence per share

Diluted earnings per share

16.2p

24.6p

41.6p

Share-based payment charges

0.6p

2.6p

5.5p

Exchange differences relating to the Swedish operations

0.7p

(0.2p)

0.5p

Losses/(gains) on derivative financial instruments

-

0.1p

-

Non-recurring royalty income

-

(3.9p)

(3.9p)

Tax effect of adjusting items

(0.3p)

0.3p

(0.5p)

Adjusted diluted earnings per share

17.2p

23.5p

43.2p

This reconciliation is provided to enable a better understanding of the Group's results.

 

 

3. Business segments

For management reporting purposes, the Group's operations are currently analysed according to the two operating segments of 'product sales, commissions and fees' and 'royalties'. These two operating segments are the basis on which the Group reports its primary segment information and on which decisions are made by the Group's Chief Executive Officer and Board of Directors, and resources allocated. The Group's chief operating decision maker is the Chief Executive Officer.

Segment information is presented below:

 

Six months
ended

Six months
 ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Revenue

 

 

 

Product sales, commissions and fees

57,165

63,953

127,210

Royalties

3,279

6,277

9,918

Total revenue

60,444

70,230

137,128

 

 

 

 

 

 

 

 

 

Six months
ended

Six months ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Result

 

 

 

Product sales, commissions and fees

                       12,767

                  18,893

33,976

Royalties

3,279

6,277

9,918

Total segment result

16,046

                  25,170

43,894

Net unallocated corporate expense

(1,001)

                 (1,960)

(4,195)

Operating profit

15,045

                  23,210

39,699

Investment income

247

192

443

Finance costs

-

                   (40)

(55)

Profit before tax

15,292

23,362

40,087

Tax

(2,797)

              (4,642)

(8,226)

Profit for the period attributable to shareholders

12,495

                18,720

31,861

 

Unallocated corporate expense relates to administrative activities which cannot be directly attributed to any of the principal product groups, including share-based payment charges and unrealised gains or losses on derivative financial instruments.

Assets in the 'product sales, commissions and fees' segment have increased by £4.0m over the period and assets in the 'royalties' segment have increased by £0.1m over the period; there have been no other material movements in segment assets during the period.

 

 

4. Income tax

The major components of income tax expense in the income statement are as follows:

 

Six months ended

Six months
 ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Current income tax

 

 

 

Income tax charge

2,448

4,391

               8,172

Deferred income tax

 

 

 

Relating to origination and reversal of temporary differences

349

         251

54

Income tax expense

2,797

            4,642

8,226

 

5. Earnings per ordinary share - basic and diluted

The calculation of basic and diluted earnings per share is based upon the following data:

 

Six months

ended

Six months
 ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Earnings

 

 

 

Earnings for the purposes of earnings per share being net profit attributable to equity holders of the parent

12,495

18,720

31,861

Number of shares

 

 

 

Weighted average number of ordinary shares for the purposes of basic earnings per share

74,667,645

73,383,574

73,652,808

Effect of dilutive potential ordinary shares:

 

 

 

Share options

2,538,590

2,777,281

2,989,912

Weighted average number of ordinary shares for the purposes of diluted earnings per share

77,206,235

76,160,855

76,642,720

 

6. Dividends

 

Six months

ended

Six months
 ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Amounts recognised as distributions to equity holders in the period:

 

 

 

Final dividend for the year ended 31 December 2013 of 5.5p (2012: 3.0p) per share

4,124

2,211

2,211

Interim dividend for the year ended 31 December 2013 of 2.5p (2012: 1.0p) per share

-

-

1,848

 Total distributions to equity holders in the period

4,124

2,211

4,059

 

The interim dividend of 3.0 pence per share has been approved by the Board and will be paid on 3 October 2014 to shareholders on the register at close of business on 5 September 2014.  The interim dividend has not been included as a liability at 30 June 2014.

 

7. Share capital

During the six months ended 30 June 2014 a total of 654,249 new ordinary shares of 10 pence each were issued under the Company's share option schemes for £712,000.

 

8. Notes to the cash flow statement

 

Six months ended

Six months
 ended

Twelve months ended

 

30 June

30 June

31 December

 

2014

2013

2013

 

(reviewed)

(reviewed)

(audited)

 

£'000

£'000

£'000

Profit before tax

           15,292

           23,362

40,087

Adjustments for:

 

 

 

Share-based payments

472

                2,014

4,204

Depreciation of property, plant and equipment

4,700

             3,585

7,410

Amortisation of intangible assets

433

                308

889

Research and development expenditure credit

(241)

-

(586)

Investment income

(247)

(192)

(443)

Finance costs

                   -

                   40

55

Foreign exchange losses/(gains)

537

(362)

(26)

Unrealised losses/(gains) on forward contracts

                    6

                    107

(9)

Loss on disposal of property, plant and equipment

               42

               39

250

Decrease in provisions

               (526)

               (243)

(555)

Operating cash flows before movements in working capital

20,468

28,658

51,276

(Increase)/decrease in inventories

(2,255)

              1,970

(2,121)

Increase in receivables

           (1,301)

           (5,021)

(2,945)

(Decrease)/increase in payables

(4,569)

            3,045

4,091

Cash generated by operations

12,343

28,652

50,301

Income taxes paid

(3,333)

            (1,393)

(5,208)

Net cash from operating activities

9,010

27,259

45,093

 

9. Date of approval of interim financial statements

The interim financial statements cover the period 1 January 2014 to 30 June 2014 and were approved by the Board on 28 August 2014.

Further copies of the interim financial statements are available from the Company's registered office, 316 Science Park, Cambridge CB4 0XR, and can be accessed on the Xaar plc website, www.xaar.com.

 

 

INTERIM REVIEW REPORT TO XAAR PLC

For the six months ended 30 June 2014

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2014 which comprises the condensed consolidated income statement, condensed consolidated statement of comprehensive income, condensed consolidated statement of financial position, condensed consolidated statement of changes in equity, condensed consolidated cash flow statement and related notes 1 to 9. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

This report is made solely to the Company in accordance with International Standard on Review Engagements (UK and Ireland) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board. Our work has been undertaken so that we might state to the Company those matters we are required to state to it in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.

 

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the Directors. The Directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

As disclosed in note 1, the annual financial statements of the Group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union.

 

Our responsibility

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2014 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

 

Deloitte LLP

Chartered Accountants and Statutory Auditor

Cambridge, United Kingdom

28 August 2014

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUWURUPCGMM

a d v e r t i s e m e n t